Royal Philips has partnered with US-based Nuance Communications to provide artificial intelligence (AI) based image interpretation and reporting capabilities to radiologists.

The partnership will see optimised workflow between Philips’ Illumeo platform and Nuance PowerScribe 360 to minimise discrepancies while improving radiology reporting, accuracy and standardisation.

Illumeo is an imaging and informatics technology that features adaptive intelligence and combines contextual awareness capabilities with advanced data analytics.

PowerScribe 360 is a real-time radiology reporting platform that is said to allow quick generation of high-quality actionable reports.

Integration of these platforms is intended to provide radiologists with access to different tools for risk stratification, report accuracy and structure, as well as rapid turnaround times.

Philips Healthcare Informatics business leader Yair Briman said: “Through this collaboration, Philips and Nuance demonstrate our commitment to deliver AI-based technology to help improve radiologists’ daily workflow and bring focus back to the patient.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
“Adaptive AI-driven solutions are expected to improve clinical and patient outcomes in the management of diseases such as lung cancer.”

“Pressured by time constraints and increased volume of studies in modern practice, radiologists will have access to AI-driven solutions and practical applications, including the integration of ACR guidelines, to help save time and effort while improving report quality.”

Adaptive AI-driven solutions are expected to improve clinical and patient outcomes in the management of diseases such as lung cancer.

Philips Lung Nodule Assessment and Comparison Option (LNA) and Illumeo tools, Nuance PowerScribe 360 reporting platforms and Lung Cancer Screening solution are currently being used to manage care programmes for lung cancer patients.

Nuance Healthcare Diagnostics vice-president and general manager Karen Holzberger said: “By accelerating the creation, access and usability of AI tools, the collaboration between Nuance and Philips will improve workflow efficiencies even further by reducing redundant tasks and helping better automate the reporting process.”